Stay updated on Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Sign up to get notified when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.

Latest updates to the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page
- Check6 days agoChange DetectedThere are no significant additions or deletions on the Study Details page for NCT03945981; the content appears unchanged between the two screenshots.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check34 days agoChange DetectedCore status messaging updated and version bumped from v3.1.0 to v3.2.0; emphasizes funding-related operational status for NIH Clinical Center.SummaryDifference2%

- Check42 days agoChange DetectedVersion metadata updated from v3.0.2 to v3.1.0. No substantive content changes detected.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%

- Check71 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as specific drug information related to Dolutegravir and associated MedlinePlus topics. Notably, previous drug information for Lamivudine has been removed.SummaryDifference3%

Stay in the know with updates to Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.